On February 23, 2022, Michigan Governor Gretchen Whitmer signed a series of three bills to regulate PBMs in the state. Among other things, the three pieces of legislation will prevent spread pricing, prohibit gag clauses, and require PBMs to obtain licenses and file transparency reports with state officials. These laws will allow consumers to get information on the “backend cost and profits of the medications they are prescribed” and enable pharmacies to get paid fairly. The Michigan law comes less than a week after the FTC deadlocked on whether to initiate a study on PBM contracting practices.

Governor Whitman recently granted pharmacists the authority to dispense insulin under certain emergency circumstances. Under Public Act 36 of 2021 (formerly SB 155), pharmacists can provide patients with a 30-day supply of insulin if the individual has a preexisting relationship with the pharmacy and the pharmacy is not able to get in touch with their primary care provider. Public Act 36 is currently in effect.

A new Michigan law will grant pharmacy professionals with more rights and responsibilities. Under SB 920, pharmacists will be able to dispense emergency60-day refills on prescription drugs, dispense and administer COVID-19 treatments, authorize drug substitutions in the case of shortages, temporarily operate in a location not designated on the pharmacy license, and oversee staff remotely. By giving pharmacists more responsibilities, SB 920 encourages the move towards provider status.

Michigan Governor Gretchen Whitmer signed into law Public Acts 124, 135, and 136 to require healthcare providers to issue all prescriptions electronically. The legislation aims to provide a consistent, secure way to prescribe controlled substances in the state, while also preventing substance abuse. It goes into effect on October 1, 2021.